For authoritative reviews of disease management and optimum drug therapy of psychiatric and neurological disease, CNS Drugs is developing into the journal healthcare decision makers turn to. The Journal aims to promote rational pharmacotherapy and disease management within the disciplines of clinical psychiatry and neurology. This is achieved by providing a regular program of review articles covering important issues in the management of psychiatric and neurological disorders that originate in the central nervous system, particularly the place in therapy and optimum use of newer and established pharmacological agents. Disease Management Articles - practical clinically relevant reviews designed to assist you in making treatment decisions. Review Articles - comprehensive and authoritative reviews that provide excellent reference, research and educational material.
All manuscripts are subject to peer review by international experts.
Letters to the Editor are welcomed, and will be considered for publication.